Reaction
Hirsutism reporting signals
As of the last recalculation, Hirsutism appears in 1,320 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 32.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valproate Sodium | 41 | 32.2 | 32.3 |
| Atropine Sulfate | 19 | 28.1 | 28.2 |
| Atropine | 14 | 26.9 | 27.0 |
| Levonorgestrel | 214 | 19.8 | 19.8 |
| Valganciclovir Hydrochloride Powder, | 13 | 17.0 | 17.0 |
| Budesonide | 56 | 15.6 | 15.6 |
| Tofacitinib Citrate | 12 | 14.6 | 14.6 |
| Cyclosporine | 95 | 14.4 | 14.4 |
| Etonogestrel And Ethinyl Estradiol | 17 | 12.2 | 12.2 |
| Lithium | 19 | 12.0 | 12.1 |
| Lithium Bromatum | 19 | 12.0 | 12.1 |
| Valganciclovir | 14 | 11.8 | 11.8 |
| Valganciclovir Hydrochloride | 14 | 11.8 | 11.8 |
| Phenytoin | 14 | 10.7 | 10.7 |
| Isosorbide Mononitrate | 13 | 10.0 | 10.0 |
| Ritonavir 100 Mg | 8 | 8.5 | 8.5 |
| Panitumumab | 8 | 8.1 | 8.1 |
| Brivaracetam | 4 | 7.0 | 7.0 |
| Medroxyprogesterone Acetate | 19 | 6.1 | 6.1 |
| Paliperidone | 8 | 5.4 | 5.4 |
| Isotretinoin | 14 | 4.5 | 4.5 |
| Drospirenone And Ethinyl Estradiol | 12 | 4.3 | 4.3 |
| Vigabatrin | 3 | 3.3 | 3.3 |
| Minoxidil Foam 5% (Womens) | 6 | 2.9 | 2.9 |
| Minoxidil | 8 | 2.8 | 2.8 |
| Etonogestrel | 6 | 2.0 | 2.0 |